Latest Proof Of Concept News

Metallium Limited has raised A$75 million in a strategic capital round led by U.S. institutional investors, accelerating its commercial operations in Texas and setting the stage for a NASDAQ listing later this year.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

WA1 Resources has revealed a substantial indicated mineral resource at its Luni Niobium Project, supported by successful metallurgical testwork and a robust financial position. The project’s strategic importance in the critical minerals sector is underscored by ongoing development and community engagement.

Identitii Limited has locked in a $0.6 million R&D loan facility to bolster its growth amid rising BNDRY platform sales, supported by an expected $0.8 million R&D rebate and a $2.9 million Rights Issue.

INOVIQ Limited has reported compelling preclinical results for its CAR-NK-exosome therapy targeting triple-negative breast cancer, showing significant tumor reduction and perfect survival in treated mice.

Sparc Technologies has achieved a significant commercial milestone with its first sale of ecosparc®, a graphene-based additive for protective coatings, to an Asian coatings company following successful proof-of-concept testing.

RocketDNA has secured approximately A$1 million in new orders from major mining clients, expanding its autonomous drone deployments and software services across Australia and Africa.

Anatara Lifesciences reports encouraging pre-clinical results for its anti-obesity candidate AOC, demonstrating significant reductions in weight regain and visceral fat in mice. However, a delay in mechanism of action studies pushes full data release to January 2026.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Altitude Minerals has confirmed promising heavy mineral sands prospectivity at its Nilpinna Tenement in South Australia, with assays revealing heavy mineral grades as high as 12.5%. The discovery opens a new frontier for exploration in the Eromanga Basin.

Ballard Mining’s latest drilling at its Mt Ida Gold Project reveals promising high-grade gold mineralisation across multiple prospects, setting the stage for an aggressive resource expansion campaign in 2026.

Prairie Lithium has locked in a decade-long agreement to supply lithium-bearing crystallite to Hydro Lithium’s South Korean refinery, marking a strategic step in its commercial-scale production and market entry.